Sandeep Laumas, CEO, Executive Chairman at INNOVATE BIOPHARMACEUTICALS, INC. (INNT), bought 1,000 shares at $1.21 ($1K) on 2019-06-13, disclosed to the SEC on 2019-06-17.
Open-market purchase of $1k INNT by CEO, Executive Chairman. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.21 | 409 | $495 | 40.7% |
| 2 | $1.22 | 591 | $721 | 59.3% |
| Total | $1.22 avg | 1,000 | $1K | 100% |
| Filing → |
| INNT | BUY | 2019-05-23 | $7K | — | Filing → |
| INNT | BUY | 2018-12-03 | $8K | — | Filing → |
| INNT | BUY | 2018-11-29 | $8K | — | Filing → |